These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 425071)

  • 1. Potential thrombogenicity of factor IX concentrates.
    Snape TJ; Bidwell E
    Thromb Haemost; 1979 Feb; 40(3):571. PubMed ID: 425071
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor IX thrombogenicity: in vivo effects on coagulation activation and a case report of disseminated intravascular coagulation.
    Small M; Lowe GD; Douglas JT; Forbes CD; Prentice CR
    Thromb Haemost; 1982 Aug; 48(1):76-7. PubMed ID: 7135346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
    Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
    J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro thrombogenicity tests of factor IX concentrates. I. A survey of available assays.
    Prowse CV; Chirnside A; Elton RA
    Thromb Haemost; 1980 Feb; 42(5):1355-67. PubMed ID: 6768149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro thrombogenicity tests of factor IX concentrates. II: effects of phospholipids and heparin.
    Prowse CV; Boffa MC; Guthrie C; Pepper DS
    Thromb Haemost; 1980 Feb; 42(5):1368-77. PubMed ID: 7368144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat treatment at 100 degrees C of factor VIII and IX coagulation factor concentrates.
    Teh LC; Woodfield DG
    Med J Aust; 1993 Sep; 159(5):355-6. PubMed ID: 8361441
    [No Abstract]   [Full Text] [Related]  

  • 7. Various prothrombin complex concentrates and their effect on coagulation and fibrinolysis in vivo.
    Hedner U; Nilsson IM; Bergentz SE
    Thromb Haemost; 1976 Apr; 35(2):386-95. PubMed ID: 989639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Technology optimization and properties study of factor IV complex concentrates].
    Zeng R; Yu R; Li X; Wu Y; Qi H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):142-4. PubMed ID: 15600207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombogenic potential of factor IX concentrates: comparison of tests.
    Middleton SM; Forbes CD; Prentice CR
    Thromb Haemost; 1979 Feb; 40(3):574-6. PubMed ID: 425073
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombogenicity screening of factor IX concentrates.
    Prowse CV; Pepper DS; Cash JD
    Thromb Haemost; 1977 Oct; 38(3):728-9. PubMed ID: 579519
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the in vitro and in vivo thrombogenic activity of factor IX concentrates using stasis (Wessler) and non-stasis rabbit models.
    Prowse CV; Williams AE
    Thromb Haemost; 1980 Oct; 44(2):81-6. PubMed ID: 6779401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the thrombogenicity of Scottish factor IX concentrates in dogs.
    Cash JD; Dalton RG; Middleton S; Smith JK
    Thromb Diath Haemorrh; 1975 Jun; 33(3):632-9. PubMed ID: 1154318
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor IX concentrates .
    Ménaché D
    Thromb Diath Haemorrh; 1975 Jun; 33(3):600-5. PubMed ID: 1154314
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: The clinical use of factor IX concentrates.
    Biggs R
    Thromb Diath Haemorrh; 1975 Jun; 33(3):403-4. PubMed ID: 1154302
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel rat model of thrombogenicity: its use in evaluation of prothrombin complex concentrates and high purity factor IX concentrates.
    McLaughlin LF; Drummond O; MacGregor IR
    Thromb Haemost; 1992 Nov; 68(5):511-5. PubMed ID: 1455396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombogenicity of factor IX concentrates: in vitro and in vivo (rabbit) studies.
    Cash JD; Owens R; Dalton RG; Prescott RJ
    Vox Sang; 1978; 35(1-2):105-10. PubMed ID: 664565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New concentrates of factors VII, IX and X.
    Menache D
    Prog Clin Biol Res; 1990; 324():177-87. PubMed ID: 2408052
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombogenicity associated with factor IX complex concentrates.
    Lusher JM
    Semin Hematol; 1991 Jul; 28(3 Suppl 6):3-5. PubMed ID: 1780767
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentially thrombogenic materials in factor IX concentrates.
    Kingdon HS; Lundblad RL; Veltkamp JJ; Aronson DL
    Thromb Diath Haemorrh; 1975 Jun; 33(3):617-31. PubMed ID: 1154317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombogenicity of factor IX concentrates and polyethylene glycol processing.
    Foster PR; Patterson MR; Johnson AJ; Middleton SM
    Thromb Res; 1980 Jan 1-15; 17(1-2):273-9. PubMed ID: 7376134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.